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1738 Abstracts December 2013was embolized with Interlock Fibered IDC (Boston Scientiﬁc) 3 mm coils.
Postembolization common hepatic angiogram revealed successful exclusion
of the sac, ﬂush occlusion of the GDA, and patent hepatic arteries. Selec-
tive celiac and SMA angiogram revealed patent vessels with no retrograde
ﬂow into the VAPA. The patient had an unremarkable postoperative
course without any further bleeding. He was discharged on postoperative
day 5. A follow-up computed tomographic angiography conﬁrmed
continued exclusion of VAPA.
Conclusions: VAPA should be included in the differential diagnosis
of patients presenting with GI bleeding. Coil embolization using microcath-
eter techniques is a suitable treatment option for this challenging clinical
condition. Advanced embolization techniques should be included in the
training and practice of modern vascular surgeons.
Selective Endovascular-First Approach for Critical Limb Ischemia
Carries Minimal Cost of Worsening Long-Term Outcomes
Karan Garg, Patrick A. Kaszubski, Rameen Moridzadeh, Caron B.
Rockman, Mark A. Adelman, Thomas S. Maldonado, Frank J. Veith,
Firas F. Mussa. NYU Langone Medical Center, New York, NY
Objectives: Treatment failures are common in patients with critical
limb ischemia (CLI) and are associated with increased risk of limb loss.
Endovascular-ﬁrst approach is associated with worse overall limb salvage
rates presumably because subsequent open bypass options are compro-
mised. To evaluate the effect of endo-ﬁrst interventions, we examined the
late outcomes of patients with failed endovascular attempts undergoing
secondary interventions.
Methods: We identiﬁed a cohort of 302 patients with CLI, from
March 2007 to December 2010. Endo-ﬁrst was selected if (1) the patient
had short (5-7 cm occlusions or stenoses in crural vessels); (2) the disease
in superﬁcial femoral artery disease was limited to TASC II A, B, or C;
and (3) no impending limb loss. Endo-ﬁrst was performed in 187. Failures
were deﬁned as recurrent clinical signs and symptoms of CLI.
Results: Secondary procedures (either endo or open) were less
common after endo-ﬁrst (endo 102 of 187, 55% vs open 71 of 105,
68%; P ¼ .029). Secondary revascularization was carried out using endo-
vascular (57 of 102), open (38 of 102) and hybrid interventions (seven
of 102). The 5-year limb salvage rate for endo-ﬁrst with a secondary inter-
vention was 83% and amputation-free survival (AFS) was 45%, and was no
different for those not requiring a secondary intervention. For failures
requiring open revascularization, the limb salvage and AFS rates at 5 years
were 87% and 59%, respectively. For those treated using endovascular
revascularization, the limb salvage and AFS rates at 5 years were 82%
and 35%, respectively.
Conclusions: Failed initial endovascular revascularizations for CLI
requiring secondary interventions (either endovascular or open) have favor-
able limb salvage rates and AFS. In patients with CLI undergoing a selective
endovascular-ﬁrst approach for revascularization, failure does not confer
poor prognosis in the long-term in properly selected patients. Furthermore,
open reconstruction options may not be compromised after an endovascular
intervention in appropriately selected patients.Fig.A Multi-Institution Series of Hypogastric Preservation During
Endovascular Repair of Aneurysms Involving the Common Iliac Artery
Grant T. Fankhausera, Gustavo Oderichb, David J. Minionc, Mark
O’Donnella, William M. Stonea, Manju Kalrab, Samuel R. Moneya. aMayo
Clinic Arizona, Phoenix, Ariz; aMayo Clinic, Rochester, Minn; aUniversity
of Kentucky, Lexington, Ky
Objectives: Iliac artery involvement can complicate endovascular
aneurysm repair (EVAR). Hypogastric artery interruption is a common
strategy used to overcome this anatomical challenge but is associated with
ischemic complications in up to 50% of cases. Studies have suggested that
hypogastric artery preservation can minimize these iatrogenic complications
with no increase in morbidity. However, speciﬁc iliac branched grafts are
currently unavailable in the United States. The purpose of this study was
to review outcomes of hypogastric preservation during EVAR utilizing
currently available techniques.
Methods: A retrospective review of consecutive cases from three insti-
tutions was performed. Hypogastric preservation was achieved using four
different techniques, depending on institutional and physician preference.
Physician-modiﬁed devices (PMD) were created by attaching a 7 mm
Dacron side branch to a standard iliac limb, then reloading the device
into a larger sheath for delivery. Trifurcated devices (TRI) utilized a second
bifurcated aortic endoprosthesis to create the iliac branched conﬁguration.
Parallel endografts involved deployment of both a hypogastric and external
iliac extension alongside each other in a common iliac limb. These were clas-
siﬁed as the Sandwich Technique (ST) when two self-expanding stent grafts
were used to create a “Double-D” conﬁguration. They were classiﬁed as
Eye of the Tiger (EOT) when a balloon-expandable stent graft was used
for the hypogastric extension and molded into an “eye” shape for the
parallel portion to facilitate apposition.
Results: Preservation was attempted for 35 hypogastric arteries in 32
patients, including 17 PMDs (48%), 5 TRIs (14%), 10 EOTs (29%), and 3
STs (9%). Primary success was achieved in 100% of cases. However, one ST
had to be converted to an EOT due to a persistent intra-operative endoleak.
There was no peri-operative mortality. Early morbidity included one CHF
exacerbation and 4 wound complications. In addition, there was one early
external iliac limb occlusion and 1 external iliac limb stenosis in the ST group
due to compression by the second parallel graft. At mean follow-up of 10
months (range, 0-30 months), no ruptures, signiﬁcant sac growth, or aneu-
rysm-related deaths occurred. Overall, four endoleaks occurred (all type II),
two of which were treated successfully by endovascular means and two were
observed. One hypogastric branch occluded at 13months in the PMDgroup.
Conclusions: Hypogastric preservation during EVAR for cases with
iliac involvement is both safe and feasible with a broad variety of techniques
that utilize currently available devices. At early to mid follow-up, gross
patency rates exceed 90%. Sample sizes are too small to demonstrate supe-
riority of any speciﬁc technique. When parallel grafts are employed, the
EOT technique may offer some beneﬁt over the ST. Hypogastric preserva-
tion can be effectively performed when clinically indicated.
Role of Cardiac Evaluation Prior to Thoracic Endovascular Aortic
Repair
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Objectives: Patients with thoracic aortic pathology undergoing
thoracic endovascular aortic repair (TEVAR) often have concomitant coro-
nary arterial disease, which may cause perioperative myocardial infarction
(MI), cardiac arrest, and/or death. Despite this risk, the need for and extent
of preoperative cardiac work-up prior to TEVAR remains undeﬁned. The
present study seeks to assess the adequacy of a limited cardiac evaluation
prior to TEVAR including assessment of cardiac symptomatology, resting
electrocardiogram (ECG), and transthoracic echocardiography (TTE) as
well as to estimate the incidence of perioperative cardiac events in patients
undergoing TEVAR.
Methods: Retrospective analysis of a prospectively maintained IRB-
approved database was performed for all patients undergoing TEVAR at
a single referral institution between May 2002 and June 2013; n ¼ 463
procedures involving TEVAR were identiﬁed. All procedures involving
median sternotomy were excluded, and n ¼ 380 procedures (n ¼ 343
patients) were included in the ﬁnal analysis. Degree of cardiac workup
was classiﬁed based upon the most invasive procedure performed preopera-
tively. Classiﬁcation was no workup, resting ECG only, resting TTE, exer-
cise/pharmacologic stress testing, or coronary angiography. Standard
Table II. Procedural indications and procedures performed
Procedure indication Procedure performed
Aneurysm
(n ¼ 225)
Dissection
(n ¼ 127)
Transection
(n ¼ 28)
P
value
Descending only repair
(n ¼ 288)
Hybrid TAAA repair
(n ¼ 65)
Any arch involvement
(n ¼ 27)
P
value
No workup 7 (3.1%) 8 (6.3%) 13 (46.4%) <.01 26 (9.0%) 1 (1.5%) 1 (3.7%) <.01
ECG only 71 (31.6%) 44 (34.7%) 12 (42.9%) 107 (37.2%) 16 (24.6%) 4 (14.8%)
Echo 131 (58.2%) 75 (59.1%) 2 (7.1%) 145 (50.4%) 42 (64.6%) 21 (77.8%)
Stress test 12 (5.3%) 0 (0%) 1 (3.4%) 8 (2.3%) 5 (7.7%) 0 (0%)
Coronary angiography 4 (1.8%) 0 (0%) 0 (0%) 2 (0.7%) 1 (1.5%) 1 (3.7%)
ECG, Electrocardiogram; TAAA, thoracoabdominal aortic aneurysm.
Table III. Perioperative characteristics/outcomes
All patients
(n ¼ 380)
No workup
(n ¼ 28)
ECG only
(n ¼ 127)
Echo
(n ¼ 208)
Stress test
(n ¼ 13)
Coronary angiography
(n ¼ 4)
P
value
Ejection fraction 53.1 6 4.8 54.4 6 1.8 53.2 6 3.9 53.1 6 5.1 51.8 6 5.1 52.5 6 3.5 .84
ASA class ¼4 151 (39.7%) 21 (75.0%) 60 (47.2%) 61 (29.3%) 6 (46.2%) 3 (75.0%) <.01
Nonelective procedure status 148 (39.0%) 24 (85.7%) 54 (42.5%) 66 (31.7%) 4 (30.8%) 0 (0.0%) <.01
Concomitant procedure or vessel Bypass
(eg, peripheral stent or vessel bypass)
156 (41.1%) 8 (28.6%) 45 (35.4%) 94 (60.3%) 7 (53.9%) 2 (50.0%) .20
Outcomes
30-day myocardial infarction 9 (2.4%) 0 (0%) 1 (0.8%) 8 (3.9%) 0 (0%) 0 (0%) .35
30-day cardiac event (MI+ cardiac arrest) 9 (2.4%) 0 (0%) 1 (0.8%) 8 (3.9%) 0 (0%) 0 (0%) .35
30-day cardiac speciﬁc mortality 3 (0.8%) 0 (0%) 1 (0.8%) 2 (1.0%) 0 (0%) 0 (0%) .98
30-day mortality 21 (5.5%) 0 (0%) 9 (7.1%) 12 (5.6%) 0 (0%) 0 (0%) .52
ECG, Electrocardiogram; ASA, American Society of Anesthesiologists; MI, myocardial infarction.
Table I. Preoperative characteristics
All patients
(n ¼ 380)
No workup
(n ¼ 28)
ECG only
(n ¼ 127)
Echo
(n ¼ 208)
Stress test
(n ¼ 13)
Coronary angiography
(n ¼ 4) P value
Age, years 64.3 6 14.7 47.5 6 16.5 63.6 6 14.8 66.7 6 13.1 66.4 6 10.3 73.8 6 11.5 <.01
Male sex 232 (61.1%) 15 (53.6%) 89 (70.1%) 118 (56.7%) 7 (53.9%) 3 (75.0%) .12
Hypertension 329 (86.6%) 14 (50.0%) 114 (89.8%) 187 (89.9%) 10 (76.9%) 4 (100.0%) <.01
Hyperlipidemia 220 (57.9%) 7 (25.0%) 76 (59.8%) 122 (58.7%) 11 (84.6%) 4 (100.0%) <.01
Known CAD 109 (28.7%) 2 (7.1%) 39 (30.7%) 59 (28.4%) 6 (46.2%) 3 (75.0%) .01
History of MI 46 (12.1%) 1 (3.6%) 10 (7.9%) 29 (13.9%) 5 (38.5%) 1 (25.0%) <.01
Congestive heart failure 24 (6.3%)/entry> 0 (0.0%) 9 (7.1%) 13 (6.3%) 1 (7.7%) 1 (25.0%) .35
Tobacco abuse 230 (60.5%) 10 (35.7%) 67 (52.8%) 140 (67.3%) 10 (76.9%) 3 (75.0%) <.01
Diabetes 57 (15.0%) 2 (7.1%) 18 (14.2%) 33 (15.9%) 3 (23.1%) 1 (25.0%) .64
ECG, Electrocardiogram; CAD, coronary artery disease; MI, myocardial infarction.
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resting ECG and/or TTE, with further workup indicated for unstable
symptoms, signiﬁcantly abnormal ECG or TTE, or multiple cardiac risk
factors. Categorical and continuous variables were compared using the c2
test and analysis of variance, respectively.
Results: Baseline characteristics are presented in the Table I; n ¼ 28
(7.4%) patients had no preoperative cardiac workup, n ¼ 127 (33.4%) had
resting ECG only, n ¼ 208 (54.7%) had a resting echo, n ¼ 13 (3.4%)
underwent stress testing, and n ¼ 4 (1.1%) had coronary angiography
(only one required preoperative percutaneous intervention) for cardiac
workup. Patients undergoing stress testing or coronary angiography were
older and had a higher incidence of known coronary artery disease (P <
.01) and prior MI (P ¼ .02). Signiﬁcant differences were noted in
procedural indications, procedure performed, patient ASA class, and
procedure status (Tables II and III). A total of n ¼ 9 (2.4%) patients
experienced a perioperative cardiac event (MI and/or cardiac arrest), with
no signiﬁcant difference noted amongst all groups (P ¼ .35), suggesting
the extent of cardiac workup was appropriate. Incidence of 30-day/in-
hospital and cardiac speciﬁc mortality was likewise similar amongst all
groups (Table III).
Conclusions: Risk of a postoperative cardiac event following TEVAR
is low (2.4%), and the data presented suggest that initial screening with
either resting TTE or ECG, in addition to assessment of cardiac symptomstatus, is adequate in the vast majority of patients. As such, we recommend
resting TTE and/or ECG as the initial cardiovascular screening mechanism
in patients undergoing TEVAR, with subsequent more invasive studies if
initial screening reveals cardiovascular abnormalities.
Retrograde Pedal Access for Patients with Critical Limb Ischemia:
Feasibility and Outcomes over a Three-Year Period
Hernan A. Bazan, Linda Le, Tara Sidhom, Melissa Donovan, Taylor Smith,
W. Charles Sternbergh III. Ochsner Clinic, New Orleans, La
Objectives: Retrograde pedal access allows the treatment of tibial
occlusive lesions when standard endovascular techniques fail. We aimed to
analyze the outcomes in patients with chronic limb ischemia Rutherford
class IV and V, who were otherwise not candidates for revascularization
thru an antegrade access or tibial bypass.
Methods: Over a three-year period, a retrograde pedal access was
selectively chosen when a popliteal or tibial lesion could not be crossed
via an antegrade approach. Retrograde pedal access was performed under
ultrasound-guidance using a 4-Fr micropuncture co-axial sheath. All inter-
ventions were performed in a sheathless fashion using a 0.014” or 0.018”
‘bareback’ wire as support for a 2 or 2.5 mm balloon catheter to cross
and treat tibial chronic total occlusions that could not be treated via an
